Allopurinol oral tablet is available as a generic drug and as brand-name drugs. Brand names: Zyloprim and Lopurin. Allopurinol is also given as an injection by a healthcare professional in the ...

Please provide your email address to receive an email when new articles are posted on . Risk of death from all causes was similarly lower for patients on hemodialysis prescribed either allopurinol or ...

Allopurinol hypersensitivity syndrome (AHS) is characterized by severe rash, fever, eosinophilia, hepatitis, and renal failure. [1] It is a feared, albeit rare, complication of therapy and is ...

ankle gout Researchers studied the comparative efficacy and safety of urate-lowering therapy – allopurinol vs febuxostat – in the treatment of gout. Allopurinol demonstrates noninferiority and ...

Research shows that a common gout medication may help reduce the risk of heart attack and stroke in people with gout.

Individuals with gout showed distinct inflammatory biomarker patterns, with profiles moving closer to those of nongout control individuals with use of treat-to-target ULT.

VANCOUVER, B.C.—Allopurinol can be prescribed safely to treat recurrent gout in renal transplant recipients who are receiving azathioprine, British researchers reported. Gout is frequently a ...

A groundbreaking new study, led by experts at the University of Nottingham, has found that medicines used to treat gout can ...

Certain textbooks/references suggest a maximum dose of allopurinol (Xyloprim, Lopurin) in patients with renal insufficiency. Presumably, this is because of renal excretion of the metabolite, ...

Elevated serum urate levels are associated with progression of chronic kidney disease. Whether urate-lowering treatment with allopurinol can attenuate the decline of the estimated glomerular ...

Please provide your email address to receive an email when new articles are posted on . Allopurinol dose escalation for patients with gout did not result in improved survival under the currently ...

The effects of allopurinol treatment on mortality among patients with gout remain uncertain, with a new meta-analysis finding conflicting results. In a systematic review of the literature that ...